ASO Author Reflections: Postoperative Radiotherapy for Patients with Mesothelioma—Past, Present, and Future

  • Gary D. Lewis
  • Bin S. TehEmail author
ASO Author Reflections



Gary D. Lewis and Bin S. Teh have no conflicts of interest to disclose.


  1. 1.
    Matsuo Y, Shibuya K, Okubo K, et al. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma. Acta Oncol (Madr). 2017;56(7):957–62. CrossRefGoogle Scholar
  2. 2.
    Okubo K, Sonobe M, Fujinaga T, et al. Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2009;57(11):585–90. CrossRefGoogle Scholar
  3. 3.
    Kristensen CA, Nøttrup TJ, Berthelsen AK, et al. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma. Radiother Oncol. 2009;92(1):96–9. CrossRefGoogle Scholar
  4. 4.
    Rosenzweig KE, Zauderer MG, Laser B, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2012;83(4):1278–83. CrossRefGoogle Scholar
  5. 5.
    Minatel E, Trovo M, Bearz A, et al. Radical radiation therapy after lung-sparing surgery for malignant pleural mesothelioma: survival, pattern of failure, and prognostic factors. Int J Radiat Oncol Biol Phys. 2015;93(3):606–13. CrossRefGoogle Scholar
  6. 6.
    Lewis GD, Dalwadi, SM, Farach A, et al. The role of adjuvant radiotherapy in the treatment of pleural mesothelioma. Ann Surg Oncol. 2019;26:1879–85.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Radiation OncologyThe University of Texas Medical Branch at GalvestonGalvestonUSA
  2. 2.Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research InstituteWeil Cornell Medical CollegeHoustonUSA

Personalised recommendations